Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
20:11:10 EST Sat 07 Feb 2026
Enter Symbol
or Name
USA
CA



Q:MMSI - MERIT MEDICAL SYSTEMS - https://www.merit.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
MMSI - Q0.570.55·85.000.182.50+2.873.6842.268,3849,55580.62  82.6625  79.95110.67  78.11616:20:00Jan 0815 min RT 2¢

Recent Trades - Last 10 of 9555
Time ETExPriceChangeVolume
16:20:00Q82.502.8776
16:10:04Q82.502.871
16:10:04Q82.502.871
16:10:04Q82.502.871
16:04:43Q82.502.871
16:04:42Q82.502.871
16:04:37Q82.502.871
16:04:12Q82.502.871
16:04:05Q82.502.871
16:01:58Q82.502.871,416

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-01-08 16:05U:MMSINews ReleaseMerit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025
2025-12-23 09:00U:MMSINews ReleaseMerit Medical to Participate at the J.P. Morgan Healthcare Conference
2025-11-13 16:05U:MMSINews ReleaseMerit Medical Provides Update on U.S. Reimbursement and Commercial Strategies for WRAPSODY(TM) Cell-Impermeable Endoprosthesis
2025-11-05 09:00U:MMSINews ReleaseMerit Medical Releases 24-Month Efficacy Results from the Randomized Arteriovenous Fistula (AVF) Arm of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial
2025-11-03 09:25U:MMSINews ReleaseMerit Medical Releases 24-Month Efficacy Results from the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY Arteriovenous Access Efficacy (WAVE) Trial
2025-10-30 16:05U:MMSINews ReleaseMerit Medical Reports Third Quarter 2025 Results and Updates Full-Year Guidance
2025-10-15 16:05U:MMSINews ReleaseMerit Medical Signs Asset Purchase Agreement with PENTAX Medical to Acquire C2 CryoBalloon Technology
2025-10-03 09:25U:MMSINews ReleaseMerit Medical Systems to Announce Third Quarter 2025 Results on October 30, 2025
2025-10-01 09:25U:MMSINews ReleaseMerit Medical Announces SCOUT Milestone: 750,000 Patients Treated with Wire-Free Technology
2025-09-12 14:30U:MMSINews ReleaseMerit Medical Embosphere Microspheres Achieve CE Mark for Genicular Artery Embolisation to Treat Knee Osteoarthritis
2025-08-18 09:25U:MMSINews ReleaseFirst Patient Enrolled in Merit Medical's WRAPSODY (WRAP) North America Registry
2025-08-07 09:25U:MMSINews ReleaseMerit Medical Launches the Prelude Wave Hydrophilic Sheath Introducer with SnapFix Technology
2025-07-30 16:05U:MMSINews ReleaseMerit Medical Reports Second Quarter 2025 Results and Updates Full-Year Guidance
2025-07-07 16:05U:MMSINews ReleaseMerit Medical Names Martha Aronson as New President and Chief Executive Officer
2025-07-03 16:05U:MMSINews ReleaseMerit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025
2025-05-20 07:30U:MMSINews ReleaseMerit Medical Acquires Biolife Delaware, L.L.C.
2025-05-06 09:25U:MMSINews ReleaseMerit Medical Announces Health Canada Approval of the WRAPSODY(TM) Cell-Impermeable Endoprosthesis
2025-05-05 09:25U:MMSINews ReleaseMerit Medical Releases 12-Month Efficacy Results for the Single-Arm Arteriovenous Graft (AVG) Cohort of the WRAPSODY(TM) Arteriovenous Efficacy (WAVE) Trial
2025-04-24 16:05U:MMSINews ReleaseMerit Medical Reports First Quarter 2025 Results and Updates Full-Year Guidance
2025-04-09 09:25U:MMSINews ReleaseMerit Medical Launches the Ventrax(TM) Delivery System